Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor β in human cancer cells - Transcriptional activation and messenger RNA stabilization

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1574, Issue 1, 2002, Pages 24-34

  Okamoto, Masahiro ^a   Ono, Mayumi ^a   Uchiumi, Takeshi ^a   Ueno, Hikaru ^b   Kohno, Kimitoshi ^b   Sugimachi, Keizo ^a   Kuwano, Michihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Epidermal growth factor; MRNA stabilization; Thrombospondin 1; Transforming growth factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA AMANITIN; EPIDERMAL GROWTH FACTOR; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR;

ARTICLE; BONE; BRAIN; CANCER CELL; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER; LIVER CELL; OSTEOSARCOMA CELL; PANCREAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RECEPTOR UPREGULATION; RNA ANALYSIS; RNA DEGRADATION; RNA STABILITY; STROMA; TRANSCRIPTION INITIATION;

BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; HUMANS; LIVER NEOPLASMS; OSTEOSARCOMA; RNA STABILITY; THROMBOSPONDIN 1; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037138818     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(01)00345-1     Document Type: Article

References (55)

1. Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1
2. Diverse mechanisms for cell attachment to platelet thrombospondin
3. Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1
4. Control of smooth muscle cell growth by components of the extracellular matrix: Autocrine role for thrombospondin
5. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation
6. Stimulation of fibroblast proliferation by thrombospondin
7. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor
8. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
9. Matrix-bound thrombospondin promotes angiogenesis in vitro
10. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
11. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression
12. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
13. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
14. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide
15. Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues
16. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study
17. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma
18. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer
19. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells
20. The molecular biologic study of the expression of thrombospondin in vascular smooth muscle cells and mesangial cells
21. Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors
22. Osteotropic factor-stimulated synthesis of thrombospondin in rat dental pulp cells
23. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability
24. Thrombospondin gene expression is associated with mitogenesis in 3T3 cells: Induction by basic fibroblast growth factor
25. Proinflammatory cytokines (interleukin-1 beta and tumor necrosis factor-alpha) down regulate synthesis and secretion of thrombospondin by human endothelial cells
26. Endothelial cell proliferation regulated by cytokines modulates thrombospondin-1 secretion into the subendothelium
27. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene
28. Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1
29. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun
30. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma
31. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
32. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
33. Structural analysis and expression of the human thrombospondin gene promoter
34. Characterization of the promoter region of the human thrombospondin gene. DNA sequences within the first intron increase transcription
35. A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene
36. Methylation and silencing of the thrombospondin-1 promoter in human cancer
37. Interferon gamma-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages
38. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture
39. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines
40. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
41. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta-induced physical and functional interactions between smads and Sp1
42. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene
43. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor muE3, and Smad proteins
44. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling
45. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin
46. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
47. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells
48. EGF stimulates gastrin promoter through activation of Sp1 kinase activity
49. Sp1 phosphorylation by Erk 2 stimulates DNA binding
50. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase
51. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy
52. Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli
53. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA
54. Transforming growth factor-beta1 stimulates multiple protein interactions at a unique cis-element in the 3′-untranslated region of the hyaluronan receptor RHAMM mRNA
55. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta